The Effect of Metformin on Prognosis in Patients With Locally Advanced Gastric Cancer Associated With Type 2 Diabetes Mellitus
Conclusions:
Metformin improves the survival of patients with gastric cancer and type 2 DM.
Source: American Journal of Clinical Oncology - Category: Cancer & Oncology Tags: Original Articles: Gastrointestinal Source Type: research
More News: Cancer | Cancer & Oncology | Diabetes | Diabetes Mellitus | Diabetes Type 2 | Endocrinology | Fortamet | Gastrectomy | Gastric (Stomach) Cancer | Gastroenterology | Metformin | Study